Clinical Trial

Perioperative HALP and Surgical Outcomes

Completed
View on ClinicalTrials.gov →
Summary
Esophagectomy is associated with substantial postoperative morbidity despite advances in perioperative care. The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) score has been proposed as a composite biomarker reflecting nutritional, inflammatory, and immune status; however, its perioperative behavior and clinical significance after esophagectomy remain unclear. This retrospective cohort study evaluates perioperative changes in HALP and examines the associations of preoperative, postoperative day 1, and postoperative day 7 HALP measurements with postoperative complications, including overall and major complications, anastomotic leakage, ICU readmission, and length of hospital stay. The study aims to clarify the potential role of perioperative HALP as a marker of postoperative recovery and adverse clinical outcomes following esophagectomy.
Trial Details
NCT Number NCT07761975
Lead Sponsor Istanbul Saglik Bilimleri University
Conditions Esophagectomy, HALP Score, Perioperative Biomarkers, Postoperative Complications, Perioperative Risk Assessment
Enrollment 131 participants
Start Date 2026-06-10
Primary Completion 2026-07-15 (estimated)
Study Completion 2026-07-22 (estimated)
Updated on ClinicalTrials.gov 2026-08-13